Video Experimental Relacionado
Updated: Sep 9, 2025

08:36
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
12.1K
La somnolencia diurna excesiva debe evaluarse sistemáticamente en personas con insomnio: un estudio basado en la
Julien Coelho1,2, Florian Pécune1, Alex Chanteclair1
1Univ. Bordeaux, SANPSY, UMR 6033, Bordeaux, France.
Journal of sleep research
|August 28, 2025
Resumen
La somnolencia diurna excesiva (EDS, por sus siglas en inglés) es común en pacientes con insomnio. Una intervención digital tratada con eficacia
Área de la Ciencia:
- Medicina del sueño
- Salud digital
- Ciencias del comportamiento
Sus antecedentes:
- El insomnio y la somnolencia diurna excesiva (EDS) ocurren con frecuencia, presentando un fenotipo de sueño complejo.
- Comprender el perfil de los insomnes y su respuesta a las intervenciones digitales es crucial para un tratamiento específico.
- La aplicación KANOPÉE proporciona una herramienta novedosa para recopilar datos de sueño y ofrecer recomendaciones de comportamiento personalizadas.
Objetivo del estudio:
- Caracterizar a las personas que experimentan insomnio y somnolencia diurna excesiva ("insomnios somnolientos").
- Evaluar la eficacia de una intervención de sueño digital de 17 días en el tratamiento de este grupo específico de pacientes.
- Identificar las comorbilidades asociadas con el fenotipo "insomne".
Principales métodos:
- Análisis de los datos de 21.590 participantes utilizando la aplicación KANOPÉE.
- Clasificación de los " insomnes soñolientos " basados en las puntuaciones de la Escala de Somnolencia de Epworth (≥11) y el Índice de Gravedad del Insomnio (≥15).
- Descripción y exclusión de las comorbilidades (p. ej., apnea del sueño, síndrome de los lomos, depresión) para su posterior análisis.
Principales resultados:
- El 47,9% de los participantes en el insomnio informaron de EDS, clasificándolos como "insomnios somnolientos".
- La depresión fue la comorbilidad más común entre los "insomnes".
- Después de excluir las comorbilidades, el 44,3% del grupo inicial de insomnio permaneció como "insomnios soñolientos", a menudo vinculados a síntomas de insomnio medio / tardío.
- La intervención digital mostró una eficacia similar para los "insomnes durmientes" en comparación con otros grupos de insomnio.
Conclusiones:
- La somnolencia diurna excesiva es muy frecuente en las personas con insomnio.
- Las enfermedades concomitantes, especialmente la depresión, explican algunos casos, pero una porción significativa de los 'insomnes' existen sin enfermedades concomitantes.
- Una intervención de sueño digital de 17 días es efectiva para tratar a los "insomnes", lo que indica el potencial de las soluciones de salud digital.
Videos de Conceptos Relacionados
Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
Substance Use Disorders Affecting Sleep
216
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
216
Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
Insomnia
124
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
124
Insufficient Sleep and Sleep Deprivation
210
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
210
Narcolepsy
197
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
197

